EFX Kre-Alkalyn is a brand of creatine supplements marketed as a superior alternative to traditional creatine monohydrate. It's known for its patented buffering process, which aims to stabilize the creatine molecule and enhance its absorption. Key Features: pH-Correct Creatine Monohydrate: Kre-Alkalyn is a buffered form of creatine monohydrate, meaning it's been synthesized to a pH level of 12-14. This buffering process is patented and aims to stabilize the creatine molecule, preventing it from breaking down into creatinine, a useless byproduct, before it reaches the muscles. Invented by Dr. Jeff Golini: The creator of Kre-Alkalyn, Dr. Jeff Golini, claims that his patented manufacturing process produces the only creatine monohydrate with a pH level of 12-14. Informed Sport Certified: EFX Kre-Alkalyn is certified by Informed Sport, meaning it has been tested for banned substances and meets the highest standards for quality and safety. Available in Multiple Forms: EFX Kre-Alkalyn is available in various forms, including powder, capsules, and tablets, offering flexibility for different preferences. Manufactured in the USA: EFX Sports manufactures its own products, ensuring quality control and transparency throughout the production process. Benefits: Increased Strength and Muscle Growth: Creatine is a well-researched supplement known for its ability to increase strength, muscle mass, and power. Kre-Alkalyn is claimed to be more effective than traditional creatine due to its higher stability and absorption. Enhanced Athletic Performance: Kre-Alkalyn can help athletes improve their overall performance by increasing power output, reducing fatigue, and accelerating recovery. No Loading Phase Required: Unlike traditional creatine, Kre-Alkalyn doesn't require a loading phase, meaning you can start experiencing benefits without having to take large doses initially. Reduced Bloating and Side Effects: Kre-Alkalyn is marketed as having fewer side effects, such as bloating and digestive discomfort, compared to traditional creatine.